Skip to content
Home/Companies/MedTech/Astraveus
Astraveus

Astraveus

MedTech·France·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Astraveus?

Astraveus is a French MedTech company, currently owned by AdBio Partners since 2023.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
AdBio Partners
Investor
AdBio Partners
AFB Fund II · 2021 · VC

Key facts

HQFrance
SectorMedTech
Websitewww.astraveus.com

More from AFB Fund II

Other portfolio companies in the same fund.

Orikine Bio
Active
BiotechSpain· 2026
AndzonBio2
AndzonBio2
Active
BiotechFrance· 2025
Cephagenix
Cephagenix
Active
BiotechDenmark· 2025
EvlaBio
Active
BiotechGermany· 2025
AndzonBio1
AndzonBio1
Active
BiotechFrance· 2024
Anoat Therapeutics
Active
BiotechFrance· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Astraveus?

Astraveus is currently owned by AdBio Partners, through AFB Fund II, since 2023.

When did AdBio Partners acquire Astraveus?

AdBio Partners acquired Astraveus in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue